About the project
ENABLE (European Academy for Biomedical Science) is an initiative funded by the European Union Horizon 2020 programme that involves four renowned European Research Institutes (IRB Barcelona – Spain, RIMLS – Netherlands, NNF CPR – Denmark, SEMM – Italy) and an innovative science communication agency (Scienseed).
ENABLE seeks to promote excellence in the biomedical sciences in Europe: supporting young researchers, strengthening scientific careers, and bringing biomedicine closer to society.
Until 2021, four European cities will host annually a 3-day international congress on biomedicine organised by and for young biomedical scientists: Barcelona 2017, Copenhagen 2018, Nijmegen 2019, Milan 2021.
If you plan to reach us by bike you probably don’t need any instructions. However, let us tell you that the Van der Valk Hotel is located at the RijnWaalpad, the fast cycling route (F 325) between Nijmegen and Arnhem.
f you don’t trust or don’t have access to navigation software, here is a wrap-up of how you can reach the venue by car.
The Van der Valk Hotel is perfectly accessible via the motorways A15, A50 and A325.
From the South (Eindhoven, Den Bosch) follow the A50 towards junction Valburg. Exit the junction and take the A15 to the East. Exit at junction Ressen and take the A325 towards Nijmegen-Noord/Lent. At the third sets of traffic lights turn left and at the next traffic light turn right. The hotel is located at your right.
From the North (Arnhem, Apeldoorn) you follow the A325 towards Nijmegen- Noord/Lent. At the third sets of traffic lights turn left (Prins Mauritssingel) and at the next traffic light turn right (station Lent). The hotel is located at your right. Please be careful by crossing the bicycle path!
The average journey time from the hotel is approximately:
The Van der Valk Hotel is located at Nijmegen Lent station and perfectly accessible with public transport. The station is situated between Nijmegen and Arnhem Central.
The bus stop next to the hotel offers a direct connection with Arnhem Central Station as well as Nijmegen Central Station.
The average journey time by train from the hotel is approximately:
IRB Barcelona is a world-class research center devoted to understanding fundamental questions about human health and disease. It was founded in October 2005 by the Government of Catalonia and the University of Barcelona.
The Institute’s missions include conducting multidisciplinary research of excellence at the unique interface between biology, chemistry and medicine, providing high-level training in the biomedical sciences to staff, students and visitors, driving innovation through active technology transfer to the benefit of society, and actively participating in an open dialogue with the public through a series of engagement and education activities.
The mission of the Radboud Institute for Molecular Life Sciences (RIMLS) is to achieve a greater understanding of the molecular mechanisms of disease.
By integrating fundamental and clinical research, the institute obtains multifaceted knowledge of (patho)physiological processes. To have a significant impact on healthcare, these findings are translated into diagnostics, therapeutics and personalized treatment strategies.
The multi-disciplinary approach to research in molecular life science is reflected in an established RIMLS Graduate School with a dedicated 2-year research honours MSc degree in Molecular Mechanisms of Disease and a follow-up 4-year PhD program.
Novo Nordisk Foundation Center for Protein Research (CPR) was established at the Faculty of Health and Medical Sciences, University of Copenhagen to promote basic and applied discovery research on human proteins of medical relevance. CPR aims to assemble protein-related technologies with revolutionary potential for understanding the complex wiring of biological systems and disease processes.
The vision of the Center is to be the world’s leading center in integrative protein technologies and their application to accelerate understanding of the biological processes underlying health and disease.
This is achieved by developing integrated protein technology platforms and management systems for large heterogeneous data to advance the understanding of complex protein networks in fundamental biology and disease, educating the next generation of top-tier protein scientists and becoming an unmatched global partner in protein research.
SEMM is a private foundation established in 2001 by a joint ministerial decree of three Italian Ministries, Health, Treasure, and Education, Scientific and Technological Research. The mission of the Scuola Europea di Medicina Molecolare (SEMM) is to promote the training and research of young scientists within emerging sectors of biomedicine.
SEMM operates within research centers of excellence bridging together higher education and front-line research training. Science covers virtually every aspect of modern Cell Biology and Molecular Biology, both from the basic and applied research points of view.
SEMM manages in agreement with the University of Milan and Naples, a PhD program in Systems Medicine which includes 5 curricula: Molecular Oncology, Human Genetics, Computational Biology, Medical Nanotechnology and Foundations of the Life Sciences Bioethics and Cognitive Sciences and a post doc program SIPOD.
Scienseed is a science communication agency based in Madrid, Spain. The company specializes in the development of communication strategies to maximize the impact of science in the general public and other relevant sectors, using video, graphic design and animation, videogames, social media campaigns, public engagement and training activities. Since 2014 Scienseed has been collaborating with research institutions and innovative companies to make their science visible. The company is currently part of three large European consortia.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 724115.